Status:
RECRUITING
Validating a Blood Test for the Detection of Traumatic Brain Injury in Children
Lead Sponsor:
University of Nebraska
Conditions:
Pediatric Traumatic Brain Injury
Eligibility:
All Genders
Up to 17 years
Brief Summary
The primary objective of this study is to establish if Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase L1 (UCH-L1) are predictive of computed tomography (CT) findings in pedi...
Detailed Description
The Centers for Disease Control and Prevention (CDC) estimates 3,000 deaths annually in children and youth from traumatic brain injury (TBI), 29,000 hospitalizations, and 400,000 emergency room visits...
Eligibility Criteria
Inclusion
- 0-17 years of age
- Presentation of non-penetrating trauma
- Blood draw within 24 hours of injury
- For TBI group: head CT or MRI obtained
Exclusion
- Presentation to Children's Nebraska after 24 hours of injury
- 18 years of age or older
Key Trial Info
Start Date :
May 14 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT06940232
Start Date
May 14 2025
End Date
December 1 2027
Last Update
July 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Nebraska
Omaha, Nebraska, United States, 68114